- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 26.10. | UK puts £100m into "world-first" AI biosecurity facility | ||
| 23.10. | ESMO26: Takeda preps filings on CLDN18.2 gastric cancer data | ||
| 23.10. | ESMO26: Tango sees 82% ORR with combo in pancreatic cancer | ||
| 23.10. | US Treasury proposes curbs on Chinese biotech deals | ||
| 23.10. | Five AI tools to spot prostate cancer backed for NHS use | ||
| 23.10. | ESMO26: Moderna, MSD reveal cancer jab data early after leak | ||
| 22.10. | AZ grabs FDA nod for Ultomiris in rare kidney disease IgAN | ||
| 22.10. | Roche posts solid results ahead of looming patent cliff | ||
| 22.10. | Clinical trial setup times fall sharply in UK | ||
| 22.10. | UK trial 'could halve time to test Alzheimer's drugs' | ||
| 21.10. | Despite US policy changes, drug prices stay stubbornly high | ||
| 21.10. | ViiV's Waterhouse exits to take the CEO job at CSL | ||
| 21.10. | CagriSema helps women lose 25% of their weight in study | ||
| 21.10. | GSK wins FDA green light for chronic hep B treatment Hibsago | ||
| 21.10. | UEGW delegates hear of strides forward in IBD treatment | ||
| 20.10. | Compounded tirzepatide recalled after FDA warning | ||
| 20.10. | Jemperli label extended to include rectal cancer | ||
| 20.10. | AI tool uses face photos to predict cancer survival | ||
| 20.10. | AZ and Oracle team up on AI platform for clinical trials | ||
| 20.10. | Roche offers $15bn for strategic-level deal with Hansoh | ||
| 20.10. | Merck KGaA buys Silence and its siRNA pipeline for $1.3bn | ||
| 19.10. | Novavax critic Shah Capital ends its activism campaign | ||
| 19.10. | UK Biobank partners industry on 'most detailed' immune map | ||
| 19.10. | Data reveal is promising for GSK's lung cancer drug ris-rez | ||
| 19.10. | Cancer biotech Nouscom adds €120m, and other financings |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.